TrialNature communications2025

Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling.

Anish Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.